We present the results of a pure retroperitoneoscopic/extraperitoneal nephroureterectomy (RENU) for upper urinary tract transitional cell cancer (UT-TCC). After establishment of RENU in benign indications (n=21 Patients), 14 patients (age range 51-92 years, mean 71.6) with UT-TCC have undergone the technique in our clinic from October 2005 to October 2008. This paper reports the operative procedure, clinical results and follow up. Total operative time was 110-240 minutes (median 154.5). Average blood loss was 132 mL. Tumor localization in oncology patients was renal pelvis (63.6%), ureter (18.2%) or both (18.2%). Postoperative tumor stages were Ta (n=2), Tis (n=2), T1 (n=3), T2 (n=3) and T3 (n=4) without lymph node involvement. No perioperative complications were observed. Urethral catheters were removed on Day 6-8 post surgery (median Day 7). Recovery to normal life activity ranged from 8 to 30 days (mean 17.8). During the 4-36 month (median 23) follow-up period, there was one mortality due to cancer progression. Four patients had developed superficial bladder cancer disease requiring regular cystoscopic resections. One patient had coincidental Bellini duct renal tumor and developed psoas metastasis after eight months. The 2-year tumor specific survival rate is 91%. The retroperitoneoscopic/ extraperitoneal nephroureterectomy is a lowrisk and minimally invasive procedure to be used whenever nephroureterectomy is indicated. It is an attractive alternative to both laparoscopic and open techniques and adheres to the oncological principles of radical nephroureterectomy. Short-term follow-up data showed no increased risk of tumor recurrence. However, long-term results are needed before this technique can be established as standard UT-TCC therapy.
Introduction
The standard treatment for transitional cell carcinoma (TCC) of the upper urinary tract is nephroureterectomy with excision of a bladder cuff. 1 Based on the first report by McDonald in 1952, several authors tried to minimize the access trauma by use of laparoscopic nephroureterectomy which was associated with less morbidity and produced long-term results comparable to those of open surgery. [2] [3] [4] [5] [6] [7] The indication for laparoscopic nephroureterectomy (LNU) in upper tract TCC has not yet been well defined, although most authors still recommend that high stage and high grade tumors should be a contraindication, 2, 4, 6 Recently, Muntener et al. reported good oncological outcome after LNU with a median follow-up time of 74 months and supported the use of LNU as the standard of care for high grade or high stage upper tract TCC. 8 The removal of the distal part of the ureter with a bladder cuff may be performed by an endoscopic transurethral detachment technique, laparoscopic dissection of the distal ureter with extravesical stapling of the bladder wall, the transurethral circumcision of the orifice and antegrade stripping (i.e. pluck-off technique), and the transvesical endoscopic detachment of the ureter (i.e. Cleveland technique). 2, 4, 7, [9] [10] [11] We have been applying a pure retroperitoneoscopic/extraperitoneal nephroureterectomy (RENU) procedure for TCC of the upper urinary tract upper urinary tract transitional cell cancer (UT-TCC) since October 2005 to minimize surgical morbidity. Evaluation of the efficacy of this technique, the operative procedure, clinical results and follow-up data are presented.
Materials and Methods
After establishment of RENU in benign indications (n=21 Patients), the technique was used in 14 patients (age range 51-92 years, mean 71.6) with UT-TCC in our clinic from October 2005 till October 2008. There were 8 men and 6 women with TCC of the renal pelvis and/or ureter. Three patients had undergone previous open abdominal procedures in the form of one appendecectomy and 2 transperitoneal hysterectomies. The open part of the procedure was not always necessary for the benign indications; these were symptomatic non-functioning kidneys due to high grade reflux (n=5) or obstructive lower ureter (n=16).
After the induction of general anesthesia, the patient was placed in a lateral position with the pelvis in an oblique position (70°) (Figure 1) . A 1 cm incision was made at the tip of the last rib along the mid-axillary line. The external, internal oblique and transversus abdominus muscle fibers were bluntly separated with a Kocher clamp. A balloon made from the middle finger of a size 8 surgical glove and tied to the top of a 12 mm trocar was then placed in the retroperitoneal space and inflated with 500-700 mL of saline to produce a working space. Inflation was maintained for a couple of minutes to allow hemostasis. The balloon was removed and the trocar was fixed in place using 0-nylon suture to prevent carbon dioxide leakage (port A). Carbon dioxide insufflation at a pressure of 13 mmHg was started to maintain the working space and diagnostic retroperitoneoscopy using a 30° optic was performed. The peritoneum was dissected from the anterior abdominal wall using the optic to insert another port (12 mm for the right side or 5 mm for the left side nephroureterectomy) in the anterior axillary line 2-3 cm above and medial to the anterior superior iliac spine (port B). The second working port was made 1 cm from the middle point of the line between both ports (port C). The whole procedure was carried out through both these ports.
Retroperitoneoscopic dissection of the kidney is performed in an en bloc fashion, together with some perirenal fat, as described in literature 4,5 ( Figure 2) . The ureter was then dissected downwards up to the bladder. This requires the surgeon and assistant to slightly modify their positions to look toward the patients' pelvis. After dissection of the ureter, lymphadenectomy was performed and lymph nodes were put in a bag to be removed through the incision later on. After ensuring adequate hemostasis and that laparoscopy was no longer required, the table is slightly tilted toward the surgeon for the open part of the procedure to be performed. A small incision (average 7 cm) was made as an elongation to port B to bring out the kidney and place it at the patient's pelvis from outside ( Figure 3A ). The dissection of the ureter is completed distally up to the bladder wall ( Figure 3B and C). At the vesicoureteral junction, the detrusor muscle was incised along the ureter in three directions while retracting the ureter proximally, thus obtaining a 2.5 cmhigh tent-shaped bladder cuff, including the intramural ureter, ureteral orifice, and vesical mucosa ( Figure 3D) .
A traction suture was made at its upper limit and the ureter was closed using a laparoscopic hemolock clip. The distal ureter with a 2.5 cm diameter bladder cuff was then progressively cut under vision with simultaneous suturing of the bladder wall. The specimen was removed intact and the bladder was completely sutured in two layers using 3-0 Vicryl sutures. The bladder was filled with saline to ensure dryness. Adrenalectomy was not necessary in any patient. Drainage tubes were placed inside the 5 mm trocar (port C or B) in the renal bed passing through the perivesical space. The rest incisions were closed at the end of the procedure ( Figure 4 ).
The drainage tube was usually removed on Day 3 post surgery and cystography was performed on Day 7 before removing the urethral catheter. All patients were followed up according to guidelines with cystoscopy, urine cytology every 3-6 months, and computed tomography every six months.
Results
The perioperative findings are shown in Tables 1 and 2 .
The operative time was 110-240 minutes (median 154.5) including the time required to resect the bladder cuff which was 20-50 min. The estimated blood loss was 50-400 ml (average 132). Median Body Mass Index was 26 kg/m 2 . Time to the first oral food intake was 8-12 h. No postoperative complications or urine leakage were observed in any of the patients. A continuous epidural analgesia was given during the initial three postoperative days; this is standard care in our clinic. Metamezole was then used when needed. The urethral catheters were removed Day 6-8 post surgery (mean Day 7). The time to recovery to normal life activity ranged from 8-30 days (mean 17.8). No patient had lymph node disease. The number of extracted lymph nodes ranged from 2 to 6 (mean 3).
Follow up was 4-36 months (median 23). One female patient had disease progression with metastasis and died from her tumor after eight months. Four patients have pT3, R0 tumor and have had no metastasis up till now. Four patients (28.6%) had developed superficial bladder cancer disease that was successfully controlled with regular cystoscopic resections. Cystoscopy in these patients assured complete removal of the ureteral end with a completely absent ipsilateral ureteric ostium. No patient experienced problems related to the operation during the entire follow-up period.
Discussion
The standard treatment for localized TCC of the renal pelvis and ureter is radical nephroureterectomy, which includes resection of the kidney and ureter with a bladder cuff. 1 Laparoscopic nephroureterectomy was developed to reduce the morbidity associated with this approach. Indeed, several investigators have recently suggested its benefits in terms of patient recovery with disease control comparable to that of traditional open surgery. [2] [3] [4] [5] [6] [7] [8] [10] [11] Laparoscopic nephroureterectomy can be performed via a transperitoneal or retroperitoneal access. The advantage of the retroperitoneal approach is partly the avoidance of intraabdominal Organ injuries and tumor spillage into the intra-abdominal cavity.
We adopted RENU as a modification of the already very good technique of retroperitoneoscopic nephrectomy established in our department. The patients with benign indications were needed to establish the technique. The open part of the procedure was not necessary in this setting but extraperitoneal laparoscopic bladder cuff excision was not a safe approach to be used for malignant indications. Another ventral trocar was needed with removal of the specimen through a similar incision. This led us to perform this part of the intervention as an open surgery approach through the extraction incision for UT-TCC indications. All patients reported uneventful follow up with disappearance of the symptoms presented (e.g. chronic pain, recurrent infections) which also confirmed the benefits of RENU for this indi- 
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cation.
This technique differs from others described in literature in that the position of the patient allows both parts of the procedure to be completed in a reasonably short time without needing to changing patient position and without causing any additional technical difficulties. Also the use of only two working trocars and a small incision as an extension of the already present medial one, away from the flank region, resulted in minimal scaring. Lastly, the extraperitoneal resection of the distal ureter with a bladder cuff was completely performed with an open surgical approach.
This technique compromises the known advantages mentioned in literature that an extraperitoneal approach to the kidneys avoids the risk of intra-abdominal urinary leakage and allows for intact specimen removal, therefore minimizing the incidence of local recurrence. 12 In the current series, no patient had local recurrence in the operative field. There were no complications regarding intra-abdominal injury. This confirms the benefit of this complete retroperitoneal/extraperitoneal approach.
The avoidance of a flank incision and the use of only 3 trocars minimizes scaring and gives better cosmetic results. This also has only a slight effect on subsequent body configuration, as stated by Yoshimura et al. 13 The technique of ureterectomy and bladder cuff excision has not yet been standardized. A number of minimal invasive approaches to the distal ureter have been reported. [2] [3] [4] [5] [6] [7] [8] However, the endoscopic techniques have a greater risk of local recurrence and stone formation in the staple lines.
14 Our exclusively extraperitoneal approach provides a greater safety margin to this part of the procedure Moreover, various authors have described different alternative methods to open dissection of the lower ureter so as to avoid exposing the urothelium, for example, after repositioning the patient through a Para rectal incision 15 or a hand-assisted technique. 16, 17 One advantage of the described RENU-technique is that the complete removal of the bladder cuff, including the ureteral orifice and vesical mucosa, could be confirmed visually during surgery. This was proved by postoperative cystoscopy which confirmed the complete absence of ipsilateral ostium. However, the biggest advantage is offered by the complete extraperitoneal excision.
Furthermore, the median of our muscle splitting incisions was 7 cm which is shorter than that used in the muscle cutting approach of open surgery and even the recently published laparoscopic series. We believe that the open part of the procedure does not adversely affect patient recovery compared with the complete retroperitoneoscopic and laparoscopic approaches. Analgesic requirements were also comparable with the published data. The short- er operative time and low blood loss may be in part due to our experience with the retroperitoneoscopic procedures. In addition, the mean operative time, time to oral diet, urethral catheter time, and length of hospital stay were also comparable with literature. A comparison between the available published series is shown in Table 3 .
Article
In our series, no case of port site metastasis was observed during the follow-up period. We routinely avoid systemic injury by meticulous preparation and by removing some Gerota fascia around the specimen.
The reported bladder recurrence rate worldwide is 9-48% with different methods used for controlling the bladder cuff. 2, 19 In the current series, bladder recurrence rate was (28.6%). Only one patient developed tumor of the bladder in the region of the ipsilateral ostium (7.1%). One patient died from distant metastasis. One patient had coincidental Bellini duct renal tumor and developed psoas metastasis (diagnosed with CT guided biopsy) after eight months.
He received radiotherapy. Lymphadenectomy was also feasible without any difficulty. None of our patients had presented or developed lymph node disease during follow up. The overall survival as seen in Table 2 is comparable with the current series. A 2-year disease specific survival of 91% may be also explained by the patient selection and short follow up.
No significant difference in disease specific or overall survival was found between both the retroperitoneoscopic nephrectomy and the open procedure. 2, [18] [19] [20] Current data confirm these results and proved the oncological safety of RENU to be comparable with the standard open nephroureterectomy approach.
The major drawbacks of this study are the limited number of patients, the limited followup time and the selected patient population. However, our main intention was to show technical feasibility and proof of adequacy using quality control parameters, such as complication rate, possibility of lymphadenektomie, and postoperative morbidity, and to propose a standardized approach that will hopefully offer a basis for comparative studies in the future.
Conclusions
The described RENU-technique is a low-risk and minimally invasive procedure and might be an attractive alternative to both laparoscopic as well as open techniques. From the oncological point of view, it is not associated with an increased risk of tumor recurrence; however, long-term follow up is necessary before this can become a standard therapy for UCC of the upper tract.
